Pharmacy Friends

Prime Therapeutics

Pharmacy Friends is a podcast dedicated to bringing industry experts to the same table to talk about what is happening in pharmacy today, what is coming in the future, and most importantly, what it means to you.

  1. JAN 30

    Assemble the Standards: Making Quality Second Nature at Prime

    Discover how Prime brings together industry recognized accreditation frameworks—like URAC, ISO, and NCQA—to create a unified, reliable approach to patient safety and operational excellence. In this episode, we break down how quality standards become everyday practice through embedded processes, continuous improvement, internal audits, and real world examples that demonstrate measurable impact for clients, members, and partners. 00:20: Intro 03:12: Importance of quality operations 15:50: Pharmacy accreditations on the frontline 22:15: Preparing for an emergency 23:25: Being a trusted partner 28:56: What's next in the quality universe? 31:52: New & emerging accreditations to watch 33:50: Closing

    38 min

  2. JAN 22

    Reimagining the Pipeline: Cell & Gene Therapy Decisions That Shape Care

    During this episode of Pharmacy Friends you’ll hear about the rapidly evolving world of cell and gene therapy, highlighting its promise, complexity, and growing impact across the health care ecosystem. Learn about the foundational definitions, emerging clinical innovations, and the expanding pipeline of therapies expected to reach the market in the coming years. It also examines regulatory developments, forecasting approaches, financial considerations, and the human elements that shape patient and provider decision‑making. Through expert insights and real‑world examples, the conversation illustrates how Prime is helping stakeholders navigate this dynamic landscape while preparing for the transformative potential of next‑generation therapies. Listen to the latest episode of the “Pharmacy Friends” podcast Read the latest Cell & Gene Pipeline Outlook Learn more about how Prime manages cell and gene therapies In this episode: 03:46 What is Cell & Gene Therapy? 04:34 What is the Cell & Gene Therapy Pipeline? 08:13 Why pay attention to cell & gene therapies? 12:45: Collaboration with all stakeholders is important to get the right therapies to patients 20:35: Digging in new therapies that are on the horizon 22:56: Importance of the FDA commissioner's national priority voucher 25:52: What to consider when these therapies are an option 28:40: Is cost a barrier to these therapies? 31:41: 2026 cell and gene therapy outlook 36:18: Closing - books and fishing

    40 min
  3. Beyond the Needle: Why Oral GLP-1s Matter Now

    12/11/2025

    Beyond the Needle: Why Oral GLP-1s Matter Now

    Learn about the FDA’s new expedited approval process for oral GLP-1 medications—a breakthrough that could transform obesity care. Host Maryam Tabatabai and Carole Kerzic talk about these once-daily pills, and their potential for the similar benefits as injectables without needles or refrigeration. With potential approval coming soon, oral GLP-1s could expand access, impact adherence, and help reshape the weight-loss market. Staying informed is critical: these drugs not only aid weight management but also improve cardiometabolic health. Tune in to learn why understanding the latest developments matters for payers, clinicians, patients, and policymakers. GLP-1 Pipeline Update: November 2025 00:00 Overview 00:49 Introduction to oral GLP-1s 02:43 Evidence from clinical trials 10:28 Big picture if FDA approves oral GLP-1s 14:08 Must know: Non-peptide vs peptide 15:45 More patient friendly formulation? 17:38 Market & timing for oral GLP-s  Content in this podcast is for informational or educational purposes only. The content also does not substitute professional medical advice or consultations with health care professionals. Always seek advice from a physician or other health care providers with any questions you have regarding a medical treatment or condition before undertaking a new health care regimen.

    22 min

  4. 10/29/2025

    Real-world evidence and innovation in managed care pharmacy: Insights from AMCP Nexus 2025

    Research is more than just finding interesting stats. It's about finding better ways to deliver savings, simplicity, and support. In this episode, you’ll hear from managed care pharmacy researchers who are doing just that, delivering data driven insights to drive affordability and access in health care.    Pat Gleason, PharmD, BCPS, FCCP, FAMCP, assistant vice president of health outcomes; Nick Friedlander, PharmD, clinical program pharmacist; and Simone Ndujiuba, PharmD, BCOP, clinical oncology pharmacist senior principal; and host Alex Cook, senior public relations manager, discuss how Prime’s research helps address affordability and accessibility issues and guides health care providers and peers toward clarity on treatment for complex health conditions.  Research topics covered: Three-Year Real-World Adherence and Persistence to Glucagon-Like Peptide-1 Receptor Agonists Among Commercially Insured Adults with Obesity without Diabetes Trends in Real-World Persistence to Weight Loss Glucagon-Like Peptide-1 Receptor Agonists from 2021 to 2024 Among Commercially Insured Adults without Diabetes — This study earned a platinum award from AMCP.  Impact of a Medical Claims Automated Glucagon Like Peptide-1 Drugs Prior Authorization Program— This study earned a gold award from AMCP.Validation of Long-term Savings from a Pharmacist-to-Prescriber Telephonic Intervention — This study earned a gold award from AMCP. Total Cost of Care and Adverse Effects Assessment of Bispecific T-cell Engagers and Chimeric Antigen Receptor T-cell Therapies for Relapsed Refractory Follicular Lymphoma   ------------------------- Content in this podcast is for informational or educational purposes only. The content also does not substitute professional medical advice or consultations with health care professionals. Always seek advice from a physician or other health care providers with any questions you have regarding a medical treatment or condition before undertaking a new health care regimen.

    40 min
  5. Signals & Solutions – GLP-1s in the data age

    10/16/2025

    Signals & Solutions – GLP-1s in the data age

    Unpacking signals emerging from claims, medical records, and patient-reported outcomes to shape the next wave of GLP-1 strategy. Listen in and hear from industry experts who explore the evolving story of GLP-1 medications. Host Maryam Tabatabai and her guests discuss three years of GLP1 research data and examine why data is essential for clinical decision support, population health, and predictive analytics. Pat Gleason, David Lassen and Sarah Taylor address why stakeholders need to think about tackling the rising costs of weight management and GLP-1 access and why they believe sharing real-world insights is important so next generation pharmacy solutions can be built. Tune in as we reveal what the latest data shows and what’s next for GLP-1 research and innovation. Learn more about developing a holistic GLP-1 strategyGet the latest GLP-1 insightsYear-3 adherence and persistence dataThe Skinny on GLP-1s: Part 1 | Part 2

    23 min
  6. On the Road at Specialty Summit: Powering Change

    09/22/2025

    On the Road at Specialty Summit: Powering Change

    We were in Times Square for our second annual “On-the-Road” at Specialty Summit Pharmacy Friends episode.  And this year we had a big presence in the big apple. Today, you get to hear from some of our brightest thought leaders who were there to share their insights. From the latest medical pharmacy trends to the importance of having a partner in developing a biosimilar strategy and finally what’s in the equation for creating innovative solutions to help people get their medicine plus so much more. Tune-in and subscribe to our podcast to learn about the latest health care and pharmacy trends.   Guests include: (00:39) Jordan Almazan, Senior Director, Clinical Strategy & Specialty Solutions (11:40) Steve Cutts, SVP, Specialty and Clinical Solutions (31:47) George Van Antwerp, SVP, Product Innovation (43:07) Dinesh Kandanchatha, SVP, Chief Information and Technology Officer(01:00:25) Roxanne Schwans, SVP, Supply Chain (01:08:12) Brian MacDonald, Senior Director, Clinical Strategy & Programs (01:21:41) David Root, VP, Government Affairs AND Caitlin Berry, Senior Principal, Government Affairs Policy Advisor

    1h 34m
  7. A New Era in Liver Health: GLP-1s and the MASH Breakthrough

    08/21/2025

    A New Era in Liver Health: GLP-1s and the MASH Breakthrough

    In this episode, our host Maryam Tabatabai is joined by three guests Olivia Pane, PharmD; Dr. Edmundo Rodriguez Frias; and Katie Lockhart, who unpack insights from Prime Therapeutics’ latest clinical report that dives into the latest evidence-based clinical insights related to the rising prevalence and significant health impact of metabolic dysfunction-associated steatohepatitis, or MASH. MASH is a silent but serious liver condition affecting over 22 million Americans, with numbers projected to rise sharply by 2030. Listeners learn about the latest major development in liver health treatment: the FDA approval of Novo Nordisk’s semaglutide – Wegovy -- as the first GLP-1 drug indicated for MASH. We explore how this development may revolutionize care and could offer a more affordable alternative to treating this condition. The Evolution of GLP-1s www.primetherapeutics.com All Pharmacy Friends episodes Metabolic dysfunction-associated steatohepatitis (MASH) – A new era in liver health The views and opinions expressed by the guest featured on this podcast are their own and do not necessarily reflect the official policy or position of Prime Therapeutics LLC, its hosts, or its affiliates. The guest's appearance on this podcast does not imply an endorsement of their views, products, or services by Prime Therapeutics LLC. All content provided is for informational purposes only and should not be construed as professional advice

    12 min
  8. Culture brings purpose to life

    08/13/2025

    Culture brings purpose to life

    Culture isn’t just a vibe — it’s a strategy. In this Pharmacy Friends episode, Prime's Erin Feigal (CHRO) and Jeff Kaczrowski (Director of Talent Acquisition) join host Laura Spitzack to explore how culture sparks innovation, drives engagement, and delivers real business results and why ignoring the idea of culture is like ignoring gravity. From cultural commitments to leadership styles, hear how Prime’s 7,000+ employees band together to  deliver results, innovate for growth, win together and do what’s right.  Whether you're leading a team or just trying to survive the next all-hands, tune in for sharp insights and how bold ideas—from mild to wild—prove culture is the ultimate business accelerator. More about Prime's culture Apply for a job at Prime www.primetherapeutics.com

    21 min
See All (50)

Trailer

5
out of 5
12 Ratings

About

Pharmacy Friends is a podcast dedicated to bringing industry experts to the same table to talk about what is happening in pharmacy today, what is coming in the future, and most importantly, what it means to you.

Information

  • Creator
    Prime Therapeutics
  • Years Active
    2021 - 2026
  • Episodes
    50
  • Rating
    Clean
  • Copyright
    © Prime Therapeutics
  • Show Website
    Pharmacy Friends